SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer
Author(s) -
Pengcheng Yu,
Weiyang He,
Yanqiang Zhang,
Can Hu,
Yue Wu,
Yi Wang,
Zhehan Bao,
Yuhang Xia,
Ruolan Zhang,
Mengxuan Cao,
Yuan Li,
Xiangdong Cheng,
Zhiyuan Xu
Publication year - 2022
Publication title -
journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.228
H-Index - 54
eISSN - 1687-8469
pISSN - 1687-8450
DOI - 10.1155/2022/8829649
Subject(s) - medicine , biomarker , immunotherapy , cancer , cancer immunotherapy , oncology , biochemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom